Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. McAlister, VC; Peltekian, KM; Malatjalian, DA; Colohan, S; MacDonald, S; Bitter-Suermann, H; MacDonald, AS
   Orthotopic liver transplantation using low-dose tacrolimus and sirolimus
   LIVER TRANSPLANTATION
   
   V.C. McAlister et al., "Orthotopic liver transplantation using low-dose tacrolimus and sirolimus", LIVER TRANS, 7(8), 2001, pp. 701-708
2. Neuhaus, P; Klupp, J; Langrehr, JM
   mTOR inhibitors: An overview
   LIVER TRANSPLANTATION
   
   P. Neuhaus et al., "mTOR inhibitors: An overview", LIVER TRANS, 7(6), 2001, pp. 473-484
3. Trotter, JF; Wachs, M; Bak, T; Trouillot, T; Stolpman, N; Everson, GT; Kam, I
   Liver transplantation using sirolimus and minimal corticosteroids (3-day taper)
   LIVER TRANSPLANTATION
   
   J.F. Trotter et al., "Liver transplantation using sirolimus and minimal corticosteroids (3-day taper)", LIVER TRANS, 7(4), 2001, pp. 343-351
4. Tassignon, J; Vandevelde, M; Goldman, M
   Azodicarbonamide as a new T cell immunosuppressant: Synergy with cyclosporin A
   CLINICAL IMMUNOLOGY
   
   J. Tassignon et al., "Azodicarbonamide as a new T cell immunosuppressant: Synergy with cyclosporin A", CLIN IMMUNO, 100(1), 2001, pp. 24-30
5. Yu, LB; Zhang, RZ; Wang, ZQ
   A new and efficient route to derivatives of (R)-4-hydroxycyclohex-2-enone
   JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
   
   L.B. Yu et al., "A new and efficient route to derivatives of (R)-4-hydroxycyclohex-2-enone", J CHEM S P1, (22), 2001, pp. 2958-2961
6. Vogt, PK
   PI 3-kinase, mTOR, protein synthesis and cancer
   TRENDS IN MOLECULAR MEDICINE
   
   P.K. Vogt, "PI 3-kinase, mTOR, protein synthesis and cancer", TRENDS MO M, 7(11), 2001, pp. 482-484
7. Miron, M; Verdu, J; Lachance, PED; Birnbaum, MJ; Lasko, PF; Sonenberg, N
   The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila
   NATURE CELL BIOLOGY
   
   M. Miron et al., "The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila", NAT CELL BI, 3(6), 2001, pp. 596-601
8. Bodine, SC; Stitt, TN; Gonzalez, M; Kline, WO; Stover, GL; Bauerlein, R; Zlotchenko, E; Scrimgeour, A; Lawrence, JC; Glass, DJ; Yancopoulos, GD
   Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy andcan prevent muscle atrophy in vivo
   NATURE CELL BIOLOGY
   
   S.C. Bodine et al., "Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy andcan prevent muscle atrophy in vivo", NAT CELL BI, 3(11), 2001, pp. 1014-1019
9. Lowden, PAS; Wilkinson, B; Bohm, GA; Handa, S; Floss, HG; Leadlay, PF; Staunton, J
   Origin and true nature of the starter unit for the rapamycin polyketide synthase
   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
   
   P.A.S. Lowden et al., "Origin and true nature of the starter unit for the rapamycin polyketide synthase", ANGEW CHEM, 40(4), 2001, pp. 777-779
10. Keller, TH; Hersperger, R; Della Cioppa, G
    Macrocyclic immunosuppressants
    NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    
    T.H. Keller et al., "Macrocyclic immunosuppressants", PROG R RES, 31, 2001, pp. 237-240
11. Seikaly, M; Ho, PL; Emmett, L; Tejani, A
    The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998
    PEDIATRIC TRANSPLANTATION
    
    M. Seikaly et al., "The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998", PEDIAT TRAN, 5(3), 2001, pp. 215-231
12. Ikeda, H; Nonomiya, T; Omura, S
    Organization of biosynthetic gene cluster for avermectin in Streptomyces avermitilis: analysis of enzymatic domains in four polyketide synthases
    JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
    
    H. Ikeda et al., "Organization of biosynthetic gene cluster for avermectin in Streptomyces avermitilis: analysis of enzymatic domains in four polyketide synthases", J IND MIC B, 27(3), 2001, pp. 170-176
13. Kimball, SR; Horetsky, RL
    Alterations in interprotein interactions between translation initiation factors assessed by fluorescence resonance energy transfer
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    
    S.R. Kimball e R.L. Horetsky, "Alterations in interprotein interactions between translation initiation factors assessed by fluorescence resonance energy transfer", INT J BIO C, 33(8), 2001, pp. 797-806
14. Yu, K; Toral-Barza, L; Discafani, C; Zhang, WG; Skotnicki, J; Frost, P; Gibbons, JJ
    mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
    ENDOCRINE-RELATED CANCER
    
    K. Yu et al., "mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer", ENDOCR-R CA, 8(3), 2001, pp. 249-258
15. Tee, AR; Proud, CG
    Staurosporine inhibits phosphorylation of translational regulators linked to mTOR
    CELL DEATH AND DIFFERENTIATION
    
    A.R. Tee e C.G. Proud, "Staurosporine inhibits phosphorylation of translational regulators linked to mTOR", CELL DEAT D, 8(8), 2001, pp. 841-849
16. Jacinto, E; Guo, B; Arndt, KT; Schmelzle, T; Hall, MN
    TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway
    MOLECULAR CELL
    
    E. Jacinto et al., "TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway", MOL CELL, 8(5), 2001, pp. 1017-1026
17. Fruchtman, S; Gift, B; Howes, B; Borski, R
    Insulin-like growth factor-I augments prolactin and inhibits growth hormone release through distinct as well as overlapping cellular signaling pathways
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    
    S. Fruchtman et al., "Insulin-like growth factor-I augments prolactin and inhibits growth hormone release through distinct as well as overlapping cellular signaling pathways", COMP BIOC B, 129(2-3), 2001, pp. 237-242
18. Kulkarni, P
    Review: Uveitis and immunosuppressive drugs
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    
    P. Kulkarni, "Review: Uveitis and immunosuppressive drugs", J OCUL PH T, 17(2), 2001, pp. 181-187
19. Gonzalez, J; Harris, T; Childs, G; Prystowsky, MB
    Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival
    BLOOD CELLS MOLECULES AND DISEASES
    
    J. Gonzalez et al., "Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival", BL CELL M D, 27(3), 2001, pp. 572-585
20. Lhoest, G; Hertsens, R; Verbeeck, RK; Maton, N; Wallemacq, P; Dehoux, JP; Latinne, D
    In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry
    JOURNAL OF MASS SPECTROMETRY
    
    G. Lhoest et al., "In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry", J MASS SPEC, 36(8), 2001, pp. 889-901
21. Jegorov, A; Havlicek, V
    Spontaneous N -> O acyl shift in the [M+H](+) ions of [MeBmt(1)]-cyclosporins in an ion trap
    JOURNAL OF MASS SPECTROMETRY
    
    A. Jegorov e V. Havlicek, "Spontaneous N -> O acyl shift in the [M+H](+) ions of [MeBmt(1)]-cyclosporins in an ion trap", J MASS SPEC, 36(6), 2001, pp. 633-640
22. Rowe, CJ; Bohm, IU; Thomas, IP; Wilkinson, B; Rudd, BAM; Foster, G; Blackaby, AP; Sidebottom, PJ; Roddis, Y; Buss, AD; Staunton, J; Leadlay, PF
    Engineering a polyketide with a longer chain by insertion of an extra module into the erythromycin-producing polyketide synthase
    CHEMISTRY & BIOLOGY
    
    C.J. Rowe et al., "Engineering a polyketide with a longer chain by insertion of an extra module into the erythromycin-producing polyketide synthase", CHEM BIOL, 8(5), 2001, pp. 475-485
23. Nishimura, T; Faul, JL; Berry, GI; Veve, I; Pearl, RG; Kao, PN
    40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertensionand neointimal formation in rats
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    T. Nishimura et al., "40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertensionand neointimal formation in rats", AM J R CRIT, 163(2), 2001, pp. 498-502
24. Riboldi-Tunnicliffe, A; Konig, B; Jessen, S; Weiss, MS; Rahfeld, J; Hacker, J; Fischer, G; Hilgenfeld, R
    Crystal structure of Mip, a prolylisomerase from Legionella pneumophila
    NATURE STRUCTURAL BIOLOGY
    
    A. Riboldi-Tunnicliffe et al., "Crystal structure of Mip, a prolylisomerase from Legionella pneumophila", NAT ST BIOL, 8(9), 2001, pp. 779-783
25. Podder, H; Stepkowski, SM; Napoli, KL; Clark, J; Verani, RR; Chou, TC; Kahan, BD
    Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    H. Podder et al., "Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations", J AM S NEPH, 12(5), 2001, pp. 1059-1071
26. Jo, D; Lyu, MS; Cho, EG; Park, D; Kozak, CA; Kim, MG
    Identification and genetic mapping of the mouse Fkbp9 gene encoding a new member of FK506-binding protein family
    MOLECULES AND CELLS
    
    D. Jo et al., "Identification and genetic mapping of the mouse Fkbp9 gene encoding a new member of FK506-binding protein family", MOL CELLS, 12(2), 2001, pp. 272-275
27. Walpoth, BH; Pavlicek, M; Celik, B; Nicolaus, B; Schaffner, T; Althaus, U; Hess, OM; Carrel, T; Morris, RE
    Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    
    B.H. Walpoth et al., "Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts", EUR J CAR-T, 19(4), 2001, pp. 487-492
28. Almawi, WY; Assi, JW; Chudzik, DM; Abou Jaoude, MM; Rieder, MJ
    Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (Tacrolimus)1
    CELL TRANSPLANTATION
    
    W.Y. Almawi et al., "Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (Tacrolimus)1", CELL TRANSP, 10(7), 2001, pp. 615-623
29. Korepanova, A; Douglas, C; Leyngold, I; Logan, TM
    N-terminal extension changes the folding mechanism of the FK506-binding protein
    PROTEIN SCIENCE
    
    A. Korepanova et al., "N-terminal extension changes the folding mechanism of the FK506-binding protein", PROTEIN SCI, 10(9), 2001, pp. 1905-1910
30. Heesom, KJ; Gampel, A; Mellor, H; Denton, RM
    Cell cycle-dependent phosphorylation of the translational repressor eIF-4Ebinding protein-1 (4E-BP1)
    CURRENT BIOLOGY
    
    K.J. Heesom et al., "Cell cycle-dependent phosphorylation of the translational repressor eIF-4Ebinding protein-1 (4E-BP1)", CURR BIOL, 11(17), 2001, pp. 1374-1379
31. Templeton, DJ
    Protein kinases: Getting NEKed for S6K activation
    CURRENT BIOLOGY
    
    D.J. Templeton, "Protein kinases: Getting NEKed for S6K activation", CURR BIOL, 11(15), 2001, pp. R596-R599
32. Calastretti, A; Rancati, F; Ceriani, MC; Asnaghi, L; Canti, G; Nicolin, A
    Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect
    EUROPEAN JOURNAL OF CANCER
    
    A. Calastretti et al., "Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect", EUR J CANC, 37(16), 2001, pp. 2121-2128
33. Brignol, N; McMahon, LM; Luo, S; Tse, FLS
    High-throughput semi-automated 96-well liquid/liquid extraction and liquidchromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY
    
    N. Brignol et al., "High-throughput semi-automated 96-well liquid/liquid extraction and liquidchromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood", RAP C MASS, 15(12), 2001, pp. 898-907
34. Calastretti, A; Bevilacqua, A; Ceriani, C; Vigano, S; Zancai, P; Capaccioli, S; Nicolin, A
    Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase
    ONCOGENE
    
    A. Calastretti et al., "Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase", ONCOGENE, 20(43), 2001, pp. 6172-6180
35. Podder, H; Podbielski, J; Hussein, I; Katz, S; Van Buren, C; Kahan, BD
    Sirolimus improves the two-year outcome of renal allografts in African-American patients
    TRANSPLANT INTERNATIONAL
    
    H. Podder et al., "Sirolimus improves the two-year outcome of renal allografts in African-American patients", TRANSPLAN I, 14(3), 2001, pp. 135-142
36. Zhang, QW; Tomita, Y; Matsuzaki, G; Uchida, T; Yoshikawa, M; Nakashima, Y; Sueishi, K; Nomoto, K; Yasui, H
    Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA
    TRANSPLANT INTERNATIONAL
    
    Q.W. Zhang et al., "Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA", TRANSPLAN I, 14(3), 2001, pp. 143-152
37. Schwarz, C; Bohmig, GA; Steininger, R; Mayer, G; Oberbauer, R
    Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    C. Schwarz et al., "Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression", NEPH DIAL T, 16(2), 2001, pp. 378-382
38. Morelon, E; Mamzer-Bruneel, MF; Peraldi, MN; Kreis, H
    Sirolimus: a new promising immunosuppressive drug. Towards a rationale forits use in renal transplantation
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    E. Morelon et al., "Sirolimus: a new promising immunosuppressive drug. Towards a rationale forits use in renal transplantation", NEPH DIAL T, 16(1), 2001, pp. 18-20
39. Hodges, CB; Maxwell, H; Beattie, TJ; Murphy, AV; Jindal, RM
    Use of rapamycin in a transplant patient who developed cyclosporin neurotoxicity
    PEDIATRIC NEPHROLOGY
    
    C.B. Hodges et al., "Use of rapamycin in a transplant patient who developed cyclosporin neurotoxicity", PED NEPHROL, 16(10), 2001, pp. 777-778
40. Nakamura, M; Ogawa, N; Shalabi, A; Maley, WR; Longo, D; Burdick, JF
    Positive effect on T-cell regulatory apoptosis by mycophenolate mofetil
    CLINICAL TRANSPLANTATION
    
    M. Nakamura et al., "Positive effect on T-cell regulatory apoptosis by mycophenolate mofetil", CLIN TRANSP, 15, 2001, pp. 36-40
41. Emami, S; Le Floch, N; Bruyneel, E; Thim, L; May, F; Westley, B; Rio, MC; Mareel, M; Gespach, C
    Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells
    FASEB JOURNAL
    
    S. Emami et al., "Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells", FASEB J, 15(2), 2001, pp. 351-361
42. Gingras, AC; Raught, B; Gygi, SP; Niedzwiecka, A; Miron, M; Burley, SK; Polakiewicz, RD; Wyslouch-Cieszynska, A; Aebersold, R; Sonenberg, N
    Hierarchical phosphorylation of the translation inhibitor 4E-BP1
    GENES & DEVELOPMENT
    
    A.C. Gingras et al., "Hierarchical phosphorylation of the translation inhibitor 4E-BP1", GENE DEV, 15(21), 2001, pp. 2852-2864
43. Wang, LM; Kubodera, S; Ueno, A; Takeda, M
    Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats
    RENAL FAILURE
    
    L.M. Wang et al., "Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats", RENAL FAIL, 23(1), 2001, pp. 11-19
44. Goodman, GR; Dissanayake, IR; Sodam, BR; Gorodetsky, E; Lu, J; Ma, YF; Jee, WSS; Epstein, S
    Immunosuppressant use without bone loss - Implications for bone loss aftertransplantation
    JOURNAL OF BONE AND MINERAL RESEARCH
    
    G.R. Goodman et al., "Immunosuppressant use without bone loss - Implications for bone loss aftertransplantation", J BONE MIN, 16(1), 2001, pp. 72-78
45. Liu, DY; Qi, SJ; Xu, DS; Zhu, SY; Chen, HF
    A new vascularized adrenal transplantation model in the rat
    MICROSURGERY
    
    D.Y. Liu et al., "A new vascularized adrenal transplantation model in the rat", MICROSURG, 21(4), 2001, pp. 124-126
46. Reis, A; Megahed, M; Reinhard, T; Braunstein, C; Godehardt, E; Sundmacher, R
    RAD, a new immunosuppressive macrolide in murine corneal transplantation
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    
    A. Reis et al., "RAD, a new immunosuppressive macrolide in murine corneal transplantation", GR ARCH CL, 239(9), 2001, pp. 689-692
47. Simamora, P; Alvarez, JM; Yalkowsky, SH
    Solubilization of rapamycin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    P. Simamora et al., "Solubilization of rapamycin", INT J PHARM, 213(1-2), 2001, pp. 25-29
48. Everett, AD; Stoops, TD; Nairn, AC; Brautigan, D
    Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    
    A.D. Everett et al., "Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes", AM J P-HEAR, 281(1), 2001, pp. H161-H167
49. Fujimura, HA
    The Saccharomyces cerevisiae MLF6/YPL244C gene, which encodes a possible yeast homologue of mammalian UDP-galactose transporter, confers resistance to the immunosuppressive drug, leflunomide
    CURRENT MICROBIOLOGY
    
    H.A. Fujimura, "The Saccharomyces cerevisiae MLF6/YPL244C gene, which encodes a possible yeast homologue of mammalian UDP-galactose transporter, confers resistance to the immunosuppressive drug, leflunomide", CURR MICROB, 43(2), 2001, pp. 93-95
50. Yeaman, SJ; Armstrong, JL; Bonavaud, SM; Poinasamy, D; Pickersgill, L; Halse, R
    Regulation of glycogen synthesis in human muscle cells
    BIOCHEMICAL SOCIETY TRANSACTIONS
    
    S.J. Yeaman et al., "Regulation of glycogen synthesis in human muscle cells", BIOCH SOC T, 29, 2001, pp. 537-541
51. Velosa, JA; Larson, TS; Gloor, JM; Stegall, MD
    Cyclosporine elimination in the presence of TOR inhibitors: Effects on renal function, acute rejection, and safety
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    J.A. Velosa et al., "Cyclosporine elimination in the presence of TOR inhibitors: Effects on renal function, acute rejection, and safety", AM J KIDNEY, 38(4), 2001, pp. S3-S10
52. Hricik, DE
    Safety and efficacy of TOR inhibitors and other immunosuppressive regimensin African-American renal transplant recipients
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    D.E. Hricik, "Safety and efficacy of TOR inhibitors and other immunosuppressive regimensin African-American renal transplant recipients", AM J KIDNEY, 38(4), 2001, pp. S11-S15
53. Ettenger, RB; Grimm, EM
    Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    R.B. Ettenger e E.M. Grimm, "Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients", AM J KIDNEY, 38(4), 2001, pp. S22-S28
54. Nahreini, P; Hovland, AR; Kumar, B; Andreatta, C; Edwards-Prasad, J; Prasad, KN
    Effects of altered cyclophilin A expression on growth and differentiation of human and mouse neuronal cells
    CELLULAR AND MOLECULAR NEUROBIOLOGY
    
    P. Nahreini et al., "Effects of altered cyclophilin A expression on growth and differentiation of human and mouse neuronal cells", CELL MOL N, 21(1), 2001, pp. 65-79
55. Ramanathan, V; Goral, S; Helderman, JH
    Renal transplantation
    SEMINARS IN NEPHROLOGY
    
    V. Ramanathan et al., "Renal transplantation", SEM NEPHROL, 21(2), 2001, pp. 213-219
56. Khan, A; Pepio, AM; Sossin, WS
    Serotonin activates s6 kinase in a rapamycin-sensitive manner in Aplysia synaptosomes
    JOURNAL OF NEUROSCIENCE
    
    A. Khan et al., "Serotonin activates s6 kinase in a rapamycin-sensitive manner in Aplysia synaptosomes", J NEUROSC, 21(2), 2001, pp. 382-391
57. Ashe, MP; Slaven, JW; De Long, SK; Ibrahimo, S; Sachs, AB
    A novel eIF2B-dependent mechanism of translational control in yeast as a response to fusel alcohols
    EMBO JOURNAL
    
    M.P. Ashe et al., "A novel eIF2B-dependent mechanism of translational control in yeast as a response to fusel alcohols", EMBO J, 20(22), 2001, pp. 6464-6474
58. Sudo, T; Ota, Y; Kotani, S; Nakao, M; Takami, Y; Takeda, S; Saya, H
    Activation of Cdh1-dependent APC is required for G(1) cell cycle arrest and DNA damage-induced G(2) checkpoint in vertebrate cells
    EMBO JOURNAL
    
    T. Sudo et al., "Activation of Cdh1-dependent APC is required for G(1) cell cycle arrest and DNA damage-induced G(2) checkpoint in vertebrate cells", EMBO J, 20(22), 2001, pp. 6499-6508
59. Yang, WM; Yao, YL; Seto, E
    The FK506-binding protein 25 functionally associates with histone deacetylases and with transcription factor YY1
    EMBO JOURNAL
    
    W.M. Yang et al., "The FK506-binding protein 25 functionally associates with histone deacetylases and with transcription factor YY1", EMBO J, 20(17), 2001, pp. 4814-4825
60. Wang, XM; Li, W; Williams, M; Terada, N; Alessi, DR; Proud, CG
    Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase
    EMBO JOURNAL
    
    X.M. Wang et al., "Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase", EMBO J, 20(16), 2001, pp. 4370-4379
61. Beyar, R; Roguin, A
    The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured?
    EUROPEAN HEART JOURNAL
    
    R. Beyar e A. Roguin, "The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured?", EUR HEART J, 22(22), 2001, pp. 2054-2057
62. Rensing, BJ; Vos, J; Smits, PC; Foley, DP; van den Brand, MJBM; van der Giessen, WJ; de Feijter, PJ; Serruys, PW
    Coronary restenosis elimination with a sirolimus eluting stent - First European human experience with 6-month angiographic and intravascular ultrasonic follow-up
    EUROPEAN HEART JOURNAL
    
    B.J. Rensing et al., "Coronary restenosis elimination with a sirolimus eluting stent - First European human experience with 6-month angiographic and intravascular ultrasonic follow-up", EUR HEART J, 22(22), 2001, pp. 2125-2130
63. Greiwe, JS; Kwon, G; McDaniel, ML; Semenkovich, CF
    Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    J.S. Greiwe et al., "Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle", AM J P-ENDO, 281(3), 2001, pp. E466-E471
64. Lynch, CJ; Patson, BJ; Goodman, SA; Trapolsi, D; Kimball, SR
    Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    C.J. Lynch et al., "Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR", AM J P-ENDO, 281(1), 2001, pp. E25-E34
65. Pang, HY; Faber, LE
    Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells
    BREAST CANCER RESEARCH AND TREATMENT
    
    H.Y. Pang e L.E. Faber, "Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells", BREAST CANC, 70(1), 2001, pp. 21-26
66. Zhu, JF; Hayakawa, A; Kakegawa, T; Kaspar, RL
    Binding of the La autoantigen to the 5 ' untranslated region of a chimerichuman translation elongation factor 1A reporter mRNA inhibits translation in vitro
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    
    J.F. Zhu et al., "Binding of the La autoantigen to the 5 ' untranslated region of a chimerichuman translation elongation factor 1A reporter mRNA inhibits translation in vitro", BBA-GENE ST, 1521(1-3), 2001, pp. 19-29
67. Chou, WL; Chang, ZF
    Cap-independent translation conferred by the 5 '-untranslated region of human thymidine kinase mRNA
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    
    W.L. Chou e Z.F. Chang, "Cap-independent translation conferred by the 5 '-untranslated region of human thymidine kinase mRNA", BBA-GENE ST, 1519(3), 2001, pp. 209-215
68. Neye, H
    Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts theinteraction with FKBP12 and FKBP52
    REGULATORY PEPTIDES
    
    H. Neye, "Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts theinteraction with FKBP12 and FKBP52", REGUL PEPT, 97(2-3), 2001, pp. 147-152
69. Taylor, PJ; Forrest, KK; Salm, P; Pillans, PI
    Single-point calibration for sirolimus quantification
    THERAPEUTIC DRUG MONITORING
    
    P.J. Taylor et al., "Single-point calibration for sirolimus quantification", THER DRUG M, 23(6), 2001, pp. 726-727
70. Napoli, KL; Taylor, PJ
    From beach to bedside: History of the development of sirolimus
    THERAPEUTIC DRUG MONITORING
    
    K.L. Napoli e P.J. Taylor, "From beach to bedside: History of the development of sirolimus", THER DRUG M, 23(5), 2001, pp. 559-586
71. Deters, M; Nolte, K; Kirchner, G; Resch, K; Kaever, V
    Comparative study analyzing effects of sirolimus-cyclosporin and sirolimus-tacrolimus combinations on bile flow in the rat
    DIGESTIVE DISEASES AND SCIENCES
    
    M. Deters et al., "Comparative study analyzing effects of sirolimus-cyclosporin and sirolimus-tacrolimus combinations on bile flow in the rat", DIG DIS SCI, 46(10), 2001, pp. 2120-2126
72. Zubrzak, P; Kaczmarek, K; Kowalski, ML; Szkudlinska, B; Zabrocki, J
    Search for new synthetic immunosuppressants. Antamanide analogues containing the tetrazole ring as a cis-peptide bond mimetic
    POLISH JOURNAL OF CHEMISTRY
    
    P. Zubrzak et al., "Search for new synthetic immunosuppressants. Antamanide analogues containing the tetrazole ring as a cis-peptide bond mimetic", POL J CHEM, 75(12), 2001, pp. 1869-1876
73. Bhandari, BK; Feliers, D; Duraisamy, S; Stewart, JL; Gingras, AC; Abboud, HE; Choudhury, GG; Sonenberg, N; Kasinath, BS
    Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells
    KIDNEY INTERNATIONAL
    
    B.K. Bhandari et al., "Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells", KIDNEY INT, 59(3), 2001, pp. 866-875
74. Saunders, RN; Metcalfe, MS; Nicholson, ML
    Rapamycin in transplantation: A review of the evidence
    KIDNEY INTERNATIONAL
    
    R.N. Saunders et al., "Rapamycin in transplantation: A review of the evidence", KIDNEY INT, 59(1), 2001, pp. 3-16
75. Yu, CC; Kelly, PA; Burckart, GJ; Zeevi, A
    Sirolimus inhibition of lymphocyte proliferation is not antagonized by ciprofloxacin and other quinolone antibiotics
    TRANSPLANTATION PROCEEDINGS
    
    C.C. Yu et al., "Sirolimus inhibition of lymphocyte proliferation is not antagonized by ciprofloxacin and other quinolone antibiotics", TRANSPLAN P, 33(6), 2001, pp. 2989-2991
76. Ponticelli, C; MacDonald, AS; Rajagopalan, P; Sindhi, R; Mathew, T
    Phase III trial of rapamune versus placebo in primary renal allograft recipients
    TRANSPLANTATION PROCEEDINGS
    
    C. Ponticelli et al., "Phase III trial of rapamune versus placebo in primary renal allograft recipients", TRANSPLAN P, 33(3), 2001, pp. 2271-2272
77. Viklicky, O; Muller, V; Zou, H; Szabo, A; Vitko, S; Heemann, U
    RAD reduces compensatory renal graft hypertrophy in a rat model of chronicrejection
    TRANSPLANTATION PROCEEDINGS
    
    O. Viklicky et al., "RAD reduces compensatory renal graft hypertrophy in a rat model of chronicrejection", TRANSPLAN P, 33(3), 2001, pp. 2320-2321
78. Brogan, IJ; Geraghty, PJ; Hutchinson, IV
    Interaction of immunophilin-binding immunosuppressives with the glucocorticoid receptor signaling pathway: Implications for transplantation
    TRANSPLANTATION PROCEEDINGS
    
    I.J. Brogan et al., "Interaction of immunophilin-binding immunosuppressives with the glucocorticoid receptor signaling pathway: Implications for transplantation", TRANSPLAN P, 33(3), 2001, pp. 2417-2419
79. Tang, AWC; Walker, RG; Nicholls, KM; Becker, GJ
    Sirolimus does not potentiate indices of chronic cyclosporin nephrotoxicity
    TRANSPLANTATION PROCEEDINGS
    
    A.W.C. Tang et al., "Sirolimus does not potentiate indices of chronic cyclosporin nephrotoxicity", TRANSPLAN P, 33(1-2), 2001, pp. 1061-1063
80. Snell, GI; Levvey, BJ; Chin, W; Kotsimbos, ATC; Whitford, H; Williams, TJ; Richardson, M
    Rescue therapy: A role for sirolimus in lung and heart transplant recipients
    TRANSPLANTATION PROCEEDINGS
    
    G.I. Snell et al., "Rescue therapy: A role for sirolimus in lung and heart transplant recipients", TRANSPLAN P, 33(1-2), 2001, pp. 1084-1085
81. Kirchner, GI; Jacobsen, W; Deters, M; Christians, U; Nashan, B; Winkler, M; Vidal, C; Kaever, V; Sewing, KF; Manns, MP
    Fast quantification method for sirolimus and its major metabolites
    TRANSPLANTATION PROCEEDINGS
    
    G.I. Kirchner et al., "Fast quantification method for sirolimus and its major metabolites", TRANSPLAN P, 33(1-2), 2001, pp. 1091-1092
82. Mahalati, K; Kahan, BD
    Sirolimus permits steroid withdrawal from a cyclosporine regimen
    TRANSPLANTATION PROCEEDINGS
    
    K. Mahalati e B.D. Kahan, "Sirolimus permits steroid withdrawal from a cyclosporine regimen", TRANSPLAN P, 33(1-2), 2001, pp. 1270-1270
83. Hong, JC; Kahan, BD
    A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation
    TRANSPLANTATION PROCEEDINGS
    
    J.C. Hong e B.D. Kahan, "A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation", TRANSPLAN P, 33(1-2), 2001, pp. 1271-1272
84. Kahan, BD; Camardo, JS
    Rapamycin: Clinical results and future opportunities
    TRANSPLANTATION
    
    B.D. Kahan e J.S. Camardo, "Rapamycin: Clinical results and future opportunities", TRANSPLANT, 72(7), 2001, pp. 1181-1193
85. Hoogeveen, RC; Ballantyne, CM; Pownall, HJ; Opekun, AR; Hachey, DL; Jaffe, JS; Oppermann, S; Kahan, BD; Morrisett, JD
    Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients
    TRANSPLANTATION
    
    R.C. Hoogeveen et al., "Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients", TRANSPLANT, 72(7), 2001, pp. 1244-1250
86. Gregory, CR; Katznelson, S; Griffey, SM; Kyles, AE; Berryman, ER
    Fluvastatin in combination with rad significantly reduces graft vascular disease in rat cardiac allografts
    TRANSPLANTATION
    
    C.R. Gregory et al., "Fluvastatin in combination with rad significantly reduces graft vascular disease in rat cardiac allografts", TRANSPLANT, 72(6), 2001, pp. 989-993
87. Johnson, RWG; Kreis, H; Oberbauer, R; Brattstrom, C; Claesson, K; Eris, J
    Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.
    TRANSPLANTATION
    
    R.W.G. Johnson et al., "Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.", TRANSPLANT, 72(5), 2001, pp. 777-786
88. Cho, CS; Burkly, LC; Fechner, JH; Kirk, AD; Oberley, TD; Dong, YC; Brunner, KG; Peters, D; Tenhoor, CN; Nadeau, K; Yagci, G; Ishido, N; Schultz, JM; Tsuchida, M; Hamawy, MM; Knechtle, SJ
    Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograftrecipients
    TRANSPLANTATION
    
    C.S. Cho et al., "Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograftrecipients", TRANSPLANT, 72(4), 2001, pp. 587-597
89. Goddard, SH; Adams, DH
    Another nail in the coffin for conventional immunosuppressive regimens with the advent of tolerizing regimens
    TRANSPLANTATION
    
    S.H. Goddard e D.H. Adams, "Another nail in the coffin for conventional immunosuppressive regimens with the advent of tolerizing regimens", TRANSPLANT, 72(1), 2001, pp. 11-12
90. Mohaupt, MG; Vogt, B; Frey, FJ
    Sirolimus-associated eyelid edema in kidney transplant recipients
    TRANSPLANTATION
    
    M.G. Mohaupt et al., "Sirolimus-associated eyelid edema in kidney transplant recipients", TRANSPLANT, 72(1), 2001, pp. 162-164
91. Hong, JC; Kahan, BD
    A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function
    TRANSPLANTATION
    
    J.C. Hong e B.D. Kahan, "A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function", TRANSPLANT, 71(9), 2001, pp. 1320-1328
92. MacDonald, AS
    A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts
    TRANSPLANTATION
    
    A.S. MacDonald, "A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts", TRANSPLANT, 71(2), 2001, pp. 271-280
93. Furness, PN
    Histopathology of chronic renal allograft dysfunction
    TRANSPLANTATION
    
    P.N. Furness, "Histopathology of chronic renal allograft dysfunction", TRANSPLANT, 71(11), 2001, pp. SS31-SS36
94. Morris, RE
    Vascular and cellular mechanisms of chronic renal allograft dysfunction
    TRANSPLANTATION
    
    R.E. Morris, "Vascular and cellular mechanisms of chronic renal allograft dysfunction", TRANSPLANT, 71(11), 2001, pp. SS37-SS41
95. Kahan, BD
    Potential therapeutic interventions to avoid or treat chronic allograft dysfunction
    TRANSPLANTATION
    
    B.D. Kahan, "Potential therapeutic interventions to avoid or treat chronic allograft dysfunction", TRANSPLANT, 71(11), 2001, pp. SS52-SS57
96. Hong, JC; Kahan, BD
    Sirolimus rescue therapy for refractory rejection in renal transplantation
    TRANSPLANTATION
    
    J.C. Hong e B.D. Kahan, "Sirolimus rescue therapy for refractory rejection in renal transplantation", TRANSPLANT, 71(11), 2001, pp. 1579-1584
97. Bai, S; Brunner, LJ; Stepkowski, SM; Napoli, KL; Kahan, BD
    Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat
    TRANSPLANTATION
    
    S. Bai et al., "Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat", TRANSPLANT, 71(11), 2001, pp. 1585-1592
98. Kahan, BD; Kaplan, B; Lorber, MI; Winkler, M; Cambon, N; Boger, RS
    RAD in de novo renal transplantation: Comparison of three doses on the incidence and severity of acute rejection
    TRANSPLANTATION
    
    B.D. Kahan et al., "RAD in de novo renal transplantation: Comparison of three doses on the incidence and severity of acute rejection", TRANSPLANT, 71(10), 2001, pp. 1400-1406
99. Levy, GA; Grant, D; Paradis, K; Campestrini, J; Smith, T; Kovarik, JM
    Pharamacokinetics and tolerability of 40-0-[2-hydroxyethyl]rapamycin in denovo liver transplant recipients
    TRANSPLANTATION
    
    G.A. Levy et al., "Pharamacokinetics and tolerability of 40-0-[2-hydroxyethyl]rapamycin in denovo liver transplant recipients", TRANSPLANT, 71(1), 2001, pp. 160-163
100. Hinterding, K; Singhanat, S; Oberer, L
     Stereoselective synthesis of polyketide fragments using a novel intramolecular Claisen-like condensation/reduction sequence
     TETRAHEDRON LETTERS
     
     K. Hinterding et al., "Stereoselective synthesis of polyketide fragments using a novel intramolecular Claisen-like condensation/reduction sequence", TETRAHEDR L, 42(48), 2001, pp. 8463-8465